Retatrutide 20MG

Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.

Clinical Data:

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)

Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 Trial

Product Care:Store in a cool, dry place away from light.  If Constituted, Please Refrigerate.   For longer term storage, freezing at -20°C is recommended to maintain integrity.

Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

Product Note: All products are shipped in lyphollized or powder form and must be reconstituted to a liquid for research and testing.  We are unable to provide any dosing instructions, however all products should be considered pharmaceutical grade.

Please see the online reconstitution calculator: Peptide Calculator